Telotristat
Modify Date: 2024-01-02 14:22:46
Telotristat structure
|
Common Name | Telotristat | ||
|---|---|---|---|---|
| CAS Number | 1033805-22-9 | Molecular Weight | 574.982 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 704.7±70.0 °C at 760 mmHg | |
| Molecular Formula | C27H26ClF3N6O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 380.0±35.7 °C | |
Use of TelotristatTelotristat ethyl (LX1606) is a novel, orally-delivered inhibitor of tryptophan hydroxylase that reduces serotonin production. |
| Name | Telotristat ethyl |
|---|---|
| Synonym | More Synonyms |
| Description | Telotristat ethyl (LX1606) is a novel, orally-delivered inhibitor of tryptophan hydroxylase that reduces serotonin production. |
|---|---|
| Related Catalog | |
| In Vivo | Telotristat ethyl (15, 50, 150, 300 mg/kg, po, qd) reduces serotonin content in the periphery, but not in the brain of the mice. Telotristat ethyl (200 mg/kg po, qd) prevents the increase in blood neutrophil counts that is observed after TNBS challenge, provides significant protection in a mouse model of inflammatory bowel disease. Telotristat ethyl (200 mg/kg po, qd) protects the mouse IBD model confirmed by histopathology evaluation[1]. Telotristat ethyl (15, 50, 150, 300 mg/kg) depletes 5-HT from the jejunum but not the brain. But Telotristat ethyl (200 mg/kg, p.o.) does not deplete enteric neuronal serotonin (5-HT), or alter constitutive gastrointestinal motility in mice. Telotristat ethyl (200 mg/kg) alleviates the severity of trinitrobenzene sulfonic acid (TNBS)-induced colitis[2]. |
| Animal Admin | For studies of the effects of peripheral TPH inhibitors on gut and brain 5-HT concentrations, LP-920540 is formulated in 0.1% Tween 80 in 0.25% methylcellulose and administered to mice once daily via oral gavage at 10 mL/kg for 4 consecutive days. Telotristat ethyl is formulated in 15% cyclodextrin (CaptisolTM, pH 3-4) or 0.25% methylcellulose and given to mice once daily via oral gavage at 10 mL/kg for 4 consecutive days. Whole brain, jejunum and colon (mesentery fat removed, gut lumen opened and blotted dry) are collected, snap frozen, and stored at -80ºC for future. LP-920540, Telotristat ethyl, LP-778914, LP-778920 and vehicle control are also formulated with 0.5% methycellulose at appropriate doses in coded vials. The contents of the coded vials are given by oral gavage in amounts determined by the weights of the recipient mice. After the experiments, results are analyzed. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 704.7±70.0 °C at 760 mmHg |
| Molecular Formula | C27H26ClF3N6O3 |
| Molecular Weight | 574.982 |
| Flash Point | 380.0±35.7 °C |
| Exact Mass | 574.170715 |
| PSA | 131.17000 |
| LogP | 5.47 |
| Vapour Pressure | 0.0±2.2 mmHg at 25°C |
| Index of Refraction | 1.621 |
|
~71%
Telotristat CAS#:1033805-22-9 |
| Literature: US2008/153852 A1, ; Page/Page column 19 ; |
|
~97%
Telotristat CAS#:1033805-22-9 |
| Literature: US2009/62540 A1, ; Page/Page column 11 ; |
|
~%
Telotristat CAS#:1033805-22-9 |
| Literature: US2009/62540 A1, ; Page/Page column 11 ; |
|
~%
Telotristat CAS#:1033805-22-9 |
| Literature: US2009/88447 A1, ; Page/Page column 8 ; US 20090088447 A1 |
| LX 1606 |
| (S)-2-amino-3-[4-(2-amino-6-{R-1-[4-chloro-2-(3-methyl-pyrazol-1-yl)-phenyl]-2,2,2-trifluoro-ethoxy}-pyrimidin-4-yl)-phenyl]-propionic acid ethyl ester |
| (2S)-2-Amino-3-[4-[2-amino-6-[[(1R)-1-[4-chloro-2-(3-methylpyrazol-1-yl)phenyl]-2,2,2-trifluoroethyl]oxy]pyrimidin-4-yl]phenyl]propionic acid ethyl ester |
| Telotristat ethyl |
| Xermelo |
| L-Phenylalanine, 4-[2-amino-6-[(1R)-1-[4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]-4-pyrimidinyl]-, ethyl ester |
| ethyl (2S)-2-amino-3-[4-[2-amino-6-[(1R)-1-[4-chloro-2-(3-methylpyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]pyrimidin-4-yl]phenyl]propanoate |
| Ethyl 4-(2-amino-6-{(1R)-1-[4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy}-4-pyrimidinyl)-L-phenylalaninate |
| (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate |
| LX1606 |